vs
John Marshall Bancorp, Inc.（JMSB）与Protalix BioTherapeutics, Inc.（PLX）财务数据对比。点击上方公司名可切换其他公司
John Marshall Bancorp, Inc.的季度营收约是Protalix BioTherapeutics, Inc.的1.8倍（$16.8M vs $9.1M），John Marshall Bancorp, Inc.净利率更高（36.3% vs -60.3%，领先96.7%），过去两年John Marshall Bancorp, Inc.的营收复合增速更高（15.3% vs -6.7%）
约翰·马歇尔银行控股公司是一家总部位于美国的银行控股企业，通过旗下全资子公司约翰·马歇尔银行开展业务，提供商业及零售银行服务，包括存款、商业贷款、住房抵押贷款等，主要服务美国大西洋中部地区的零售客户和中小微企业。
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
JMSB vs PLX — 直观对比
营收规模更大
JMSB
是对方的1.8倍
$9.1M
净利率更高
JMSB
高出96.7%
-60.3%
两年增速更快
JMSB
近两年复合增速
-6.7%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.8M | $9.1M |
| 净利润 | $6.1M | $-5.5M |
| 毛利率 | — | 49.4% |
| 营业利润率 | — | -51.1% |
| 净利率 | 36.3% | -60.3% |
| 营收同比 | — | -49.9% |
| 净利润同比 | 26.8% | -184.8% |
| 每股收益（稀释后） | $0.43 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收JMSBPLX
| Q1 26 | $16.8M | — | ||
| Q4 25 | $16.4M | $9.1M | ||
| Q3 25 | $16.3M | $17.9M | ||
| Q2 25 | $15.4M | $15.7M | ||
| Q1 25 | $14.6M | $10.1M | ||
| Q4 24 | $14.3M | $18.2M | ||
| Q3 24 | $13.8M | $18.0M | ||
| Q2 24 | $12.6M | $13.5M |
净利润JMSBPLX
| Q1 26 | $6.1M | — | ||
| Q4 25 | $5.9M | $-5.5M | ||
| Q3 25 | $5.4M | $2.4M | ||
| Q2 25 | $5.1M | $164.0K | ||
| Q1 25 | $4.8M | $-3.6M | ||
| Q4 24 | $4.8M | $6.5M | ||
| Q3 24 | $4.2M | $3.2M | ||
| Q2 24 | $3.9M | $-2.2M |
毛利率JMSBPLX
| Q1 26 | — | — | ||
| Q4 25 | — | 49.4% | ||
| Q3 25 | — | 53.4% | ||
| Q2 25 | — | 62.5% | ||
| Q1 25 | — | 19.1% | ||
| Q4 24 | — | 78.7% | ||
| Q3 24 | — | 53.4% | ||
| Q2 24 | — | 29.8% |
营业利润率JMSBPLX
| Q1 26 | — | — | ||
| Q4 25 | 47.4% | -51.1% | ||
| Q3 25 | 42.2% | 11.9% | ||
| Q2 25 | 42.7% | 7.5% | ||
| Q1 25 | 42.4% | -41.0% | ||
| Q4 24 | 42.5% | 39.6% | ||
| Q3 24 | 38.8% | 22.2% | ||
| Q2 24 | 39.7% | -18.0% |
净利率JMSBPLX
| Q1 26 | 36.3% | — | ||
| Q4 25 | 36.2% | -60.3% | ||
| Q3 25 | 33.2% | 13.2% | ||
| Q2 25 | 33.1% | 1.0% | ||
| Q1 25 | 32.9% | -35.8% | ||
| Q4 24 | 33.3% | 35.6% | ||
| Q3 24 | 30.7% | 18.0% | ||
| Q2 24 | 30.9% | -16.4% |
每股收益（稀释后）JMSBPLX
| Q1 26 | $0.43 | — | ||
| Q4 25 | $0.41 | $-0.06 | ||
| Q3 25 | $0.38 | $0.03 | ||
| Q2 25 | $0.36 | $0.00 | ||
| Q1 25 | $0.34 | $-0.05 | ||
| Q4 24 | $0.33 | $0.10 | ||
| Q3 24 | $0.30 | $0.03 | ||
| Q2 24 | $0.27 | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $150.2M | $14.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $268.1M | $48.2M |
| 总资产 | $2.4B | $82.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资JMSBPLX
| Q1 26 | $150.2M | — | ||
| Q4 25 | $130.0M | $14.7M | ||
| Q3 25 | $163.6M | $13.6M | ||
| Q2 25 | $116.9M | $17.9M | ||
| Q1 25 | $169.1M | $19.5M | ||
| Q4 24 | $122.5M | $19.8M | ||
| Q3 24 | $177.2M | $27.4M | ||
| Q2 24 | $182.6M | $23.4M |
总债务JMSBPLX
| Q1 26 | — | — | ||
| Q4 25 | $80.9M | — | ||
| Q3 25 | $80.9M | — | ||
| Q2 25 | $80.8M | — | ||
| Q1 25 | $80.8M | — | ||
| Q4 24 | $80.8M | — | ||
| Q3 24 | $80.8M | — | ||
| Q2 24 | $24.7M | — |
股东权益JMSBPLX
| Q1 26 | $268.1M | — | ||
| Q4 25 | $265.6M | $48.2M | ||
| Q3 25 | $259.7M | $52.9M | ||
| Q2 25 | $253.7M | $49.9M | ||
| Q1 25 | $253.0M | $45.2M | ||
| Q4 24 | $246.6M | $43.2M | ||
| Q3 24 | $243.1M | $32.4M | ||
| Q2 24 | $235.3M | $28.6M |
总资产JMSBPLX
| Q1 26 | $2.4B | — | ||
| Q4 25 | $2.3B | $82.3M | ||
| Q3 25 | $2.3B | $82.3M | ||
| Q2 25 | $2.3B | $78.5M | ||
| Q1 25 | $2.3B | $73.9M | ||
| Q4 24 | $2.2B | $73.4M | ||
| Q3 24 | $2.3B | $61.6M | ||
| Q2 24 | $2.3B | $91.5M |
负债/权益比JMSBPLX
| Q1 26 | — | — | ||
| Q4 25 | 0.30× | — | ||
| Q3 25 | 0.31× | — | ||
| Q2 25 | 0.32× | — | ||
| Q1 25 | 0.32× | — | ||
| Q4 24 | 0.33× | — | ||
| Q3 24 | 0.33× | — | ||
| Q2 24 | 0.11× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $2.0M |
| 自由现金流经营现金流 - 资本支出 | — | $1.6M |
| 自由现金流率自由现金流/营收 | — | 17.8% |
| 资本支出强度资本支出/营收 | — | 4.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-13.6M |
8季度趋势，按日历期对齐
经营现金流JMSBPLX
| Q1 26 | — | — | ||
| Q4 25 | $22.6M | $2.0M | ||
| Q3 25 | $1.2M | $-3.7M | ||
| Q2 25 | $7.5M | $-5.2M | ||
| Q1 25 | $7.0M | $-5.1M | ||
| Q4 24 | $17.3M | $4.0M | ||
| Q3 24 | $1.4M | $4.1M | ||
| Q2 24 | $10.2M | $-3.6M |
自由现金流JMSBPLX
| Q1 26 | — | — | ||
| Q4 25 | $22.0M | $1.6M | ||
| Q3 25 | $1.2M | $-4.2M | ||
| Q2 25 | $7.4M | $-5.7M | ||
| Q1 25 | $6.6M | $-5.4M | ||
| Q4 24 | $16.8M | $3.6M | ||
| Q3 24 | $1.3M | $4.0M | ||
| Q2 24 | $10.1M | $-3.8M |
自由现金流率JMSBPLX
| Q1 26 | — | — | ||
| Q4 25 | 134.7% | 17.8% | ||
| Q3 25 | 7.3% | -23.7% | ||
| Q2 25 | 47.8% | -36.2% | ||
| Q1 25 | 45.3% | -53.0% | ||
| Q4 24 | 116.9% | 19.6% | ||
| Q3 24 | 9.5% | 22.4% | ||
| Q2 24 | 80.1% | -28.1% |
资本支出强度JMSBPLX
| Q1 26 | — | — | ||
| Q4 25 | 3.4% | 4.4% | ||
| Q3 25 | 0.2% | 2.8% | ||
| Q2 25 | 1.0% | 2.8% | ||
| Q1 25 | 2.3% | 3.0% | ||
| Q4 24 | 3.4% | 2.3% | ||
| Q3 24 | 0.8% | 0.5% | ||
| Q2 24 | 0.4% | 1.3% |
现金转化率JMSBPLX
| Q1 26 | — | — | ||
| Q4 25 | 3.82× | — | ||
| Q3 25 | 0.23× | -1.58× | ||
| Q2 25 | 1.48× | -31.91× | ||
| Q1 25 | 1.45× | — | ||
| Q4 24 | 3.61× | 0.61× | ||
| Q3 24 | 0.33× | 1.27× | ||
| Q2 24 | 2.60× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
JMSB
| Net Interest Income | $16.5M | 98% |
| Noninterest Income | $284.0K | 2% |
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
